Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarit Sarlomo-Rikala

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 28, 2013
Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasmsMarkku Miettinen, Maarit Sarlomo-Rikala, Peter McCue, et al.
The American Journal of Surgical Pathology|October 23, 2013
GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumorsMarkku Miettinen, Peter A McCue, Maarit Sarlomo-Rikala, et al.
Human Pathology|December 24, 2003
KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal originJerzy Lasota, Janusz Kopczynski, Maarit Sarlomo-Rikala, et al.
British Journal of Cancer|March 24, 2017
SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumourOlli-Pekka Pulkka, Bengt Nilsson, Maarit Sarlomo-Rikala, et al.
The American Journal of Surgical Pathology|February 28, 2015
Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumorsMarkku Miettinen, Peter A McCue, Maarit Sarlomo-Rikala, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 23, 2016
Frequency and clinicopathologic profile of PIK3CA mutant GISTs: molecular genetic study of 529 casesJerzy Lasota, Anna Felisiak-Golabek, Bartosz Wasag, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 19, 2003
Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable courseJerzy Lasota, Agnieszka Dansonka-Mieszkowska, Tomasz Stachura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Molecular subtypes of breast cancers detected in mammography screening and outside of screeningHarri Sihto, Johan Lundin, Tiina Lehtimäki, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 6, 2017
SP174 Antibody Lacks Specificity for NRAS Q61R and Cross-Reacts With HRAS and KRAS Q61R Mutant Proteins in Malignant MelanomaAnna Felisiak-Goląbek, Shingo Inaguma, Artur Kowalik, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 17, 2007
Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumorsJerzy Lasota, Anna Jerzak vel Dobosz, Bartosz Wasag, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 28, 2013
Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasmsMarkku Miettinen, Maarit Sarlomo-Rikala, Peter McCue, et al.
The American Journal of Surgical Pathology|October 23, 2013
GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumorsMarkku Miettinen, Peter A McCue, Maarit Sarlomo-Rikala, et al.
Human Pathology|December 24, 2003
KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal originJerzy Lasota, Janusz Kopczynski, Maarit Sarlomo-Rikala, et al.
British Journal of Cancer|March 24, 2017
SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumourOlli-Pekka Pulkka, Bengt Nilsson, Maarit Sarlomo-Rikala, et al.
The American Journal of Surgical Pathology|February 28, 2015
Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumorsMarkku Miettinen, Peter A McCue, Maarit Sarlomo-Rikala, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 23, 2016
Frequency and clinicopathologic profile of PIK3CA mutant GISTs: molecular genetic study of 529 casesJerzy Lasota, Anna Felisiak-Golabek, Bartosz Wasag, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 19, 2003
Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable courseJerzy Lasota, Agnieszka Dansonka-Mieszkowska, Tomasz Stachura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Molecular subtypes of breast cancers detected in mammography screening and outside of screeningHarri Sihto, Johan Lundin, Tiina Lehtimäki, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 6, 2017
SP174 Antibody Lacks Specificity for NRAS Q61R and Cross-Reacts With HRAS and KRAS Q61R Mutant Proteins in Malignant MelanomaAnna Felisiak-Goląbek, Shingo Inaguma, Artur Kowalik, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 17, 2007
Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumorsJerzy Lasota, Anna Jerzak vel Dobosz, Bartosz Wasag, et al.
Pageof 4